AI-driven – Page 2

As Drug Resistance Rises, GramEye and GSK Advance New AI-Led Infectious Disease Research

2 months ago talkbio0Tagged AI-driven, Antibiotics, Antimicrobial Resistance, Clinical Trials, Communicable Diseases, Drug Discovery, Gram-negative bacteria, GramEye, Mycoses, research, SmithKline Beecham, Staphylococcus aureus, superbugs

antimicrobial resistance (AMR); GramEye; GSK; AI-driven drug discovery; Gram-negative bacteria; Staphylococcus aureus; fungal infections; novel antibiotics; superbugs; infectious disease research; clinical trials

MediKarma Scales Its Clinical And Commercial Acumen With Appointment Of Dr. Scott Howell As Chief Clinical Officer And Angela Breton As Chief Revenue Officer

2 months ago talkbio0Tagged AI-driven, Angela Breton, Chief Clinical Officer, Chief Revenue Officer, MediKarma, Patient data, Platform, proactive care, Scott Howell

MediKarma; Scott Howell; Angela Breton; Chief Clinical Officer; Chief Revenue Officer; AI-driven platform; patient data; proactive care

Creative Biolabs Sets the Bar Higher in Human Antibody Discovery with Cutting-Edge Platforms

3 months ago talkbio0Tagged AI-driven, antibody libraries, Creative Biolabs, Discover, Drug Development, Generative AI, human antibody, platforms

Creative Biolabs; human antibody discovery; AI-driven platforms; generative AI; antibody libraries; drug development

Synbio International Inc. Expands Its Board of Directors and Strengthens Clinical Leadership

3 months ago talkbio0Tagged AI-driven, board of directors, Chief Financial Officer, Clinical Trials, Desiree Cain, Diagnostics, Nick Vatakis, Physician Executives, Synbio International Inc.

Synbio International Inc.; board of directors; Nick Vatakis; Desiree Cain; Medical Director; Chief Financial Officer; clinical trial; AI-driven diagnostics